BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schwimmer JB, McGreal N, Deutsch R, Finegold MJ, Lavine JE. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics. 2005;115:e561-e565. [PMID: 15867021 DOI: 10.1542/peds.2004-1832] [Cited by in Crossref: 251] [Cited by in F6Publishing: 227] [Article Influence: 14.8] [Reference Citation Analysis]
Number Citing Articles
1 Joshi D, Gupta N, Samyn M, Deheragoda M, Dobbels F, Heneghan MA. The management of childhood liver diseases in adulthood. Journal of Hepatology 2017;66:631-44. [DOI: 10.1016/j.jhep.2016.11.013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
2 Fernandes DM, Pantangi V, Azam M, Salomao M, Iuga AC, Lefkowitch JH, Gill J, Morotti R, Lavine JE, Mencin AA. Pediatric Nonalcoholic Fatty Liver Disease in New York City: An Autopsy Study. The Journal of Pediatrics 2018;200:174-80. [DOI: 10.1016/j.jpeds.2018.04.047] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
3 Jiang ZG, Mukamal K, Tapper E, Robson SC, Tsugawa Y. Low LDL-C and high HDL-C levels are associated with elevated serum transaminases amongst adults in the United States: a cross-sectional study. PLoS One 2014;9:e85366. [PMID: 24454851 DOI: 10.1371/journal.pone.0085366] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
4 Freemark M. Liver dysfunction in paediatric obesity: a randomized, controlled trial of metformin. Acta Paediatr 2007;96:1326-32. [PMID: 17718786 DOI: 10.1111/j.1651-2227.2007.00429.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
5 Di Bonito P, Sanguigno E, Di Fraia T, Forziato C, Boccia G, Saitta F, Iardino MR, Capaldo B. Association of elevated serum alanine aminotransferase with metabolic factors in obese children: sex-related analysis. Metabolism 2009;58:368-72. [PMID: 19217453 DOI: 10.1016/j.metabol.2008.10.010] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
6 Argo CK, Caldwell SH. Epidemiology and Natural History of Non-Alcoholic Steatohepatitis. Clinics in Liver Disease 2009;13:511-31. [DOI: 10.1016/j.cld.2009.07.005] [Cited by in Crossref: 247] [Cited by in F6Publishing: 223] [Article Influence: 19.0] [Reference Citation Analysis]
7 Loy JJ, Youn HA, Schwack B, Kurian M, Ren Fielding C, Fielding GA. Improvement in nonalcoholic fatty liver disease and metabolic syndrome in adolescents undergoing bariatric surgery. Surg Obes Relat Dis. 2015;11:442-449. [PMID: 25820083 DOI: 10.1016/j.soard.2014.11.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
8 Alisi A, Manco M, Devito R, Nobili V. Fatty Liver Disease. In: Freemark M, editor. Pediatric Obesity. New York: Springer; 2010. pp. 201-22. [DOI: 10.1007/978-1-60327-874-4_15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Klein M, Iazzettii L, Speiser P, Carey D, Shelov S, Accacha S, Fennoy I, Rosenbaum M, Rapaport R. Alanine transferase: An independent indicator of adiposity related comorbidity risk in youth. J Diabetes 2015;7:649-56. [PMID: 25266069 DOI: 10.1111/1753-0407.12221] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
10 Maskarinec G, Garber AK, Wong MC, Kelly N, Kazemi L, Buchthal SD, Fearnbach N, Heymsfield SB, Shepherd JA. Predictors of liver fat among children and adolescents from five different ethnic groups. Obes Sci Pract 2021;7:53-62. [PMID: 33680492 DOI: 10.1002/osp4.459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Medrano M, Maiz E, Maldonado-martín S, Arenaza L, Rodríguez-vigil B, Ortega F, Ruiz J, Larrarte E, Diez-lópez I, Sarasúa-miranda A, Tobalina I, Barrenechea L, Pérez-asenjo J, Kannengiesser S, Manhães-savio A, Echaniz O, Labayen I. The effect of a multidisciplinary intervention program on hepatic adiposity in overweight-obese children: protocol of the EFIGRO study. Contemporary Clinical Trials 2015;45:346-55. [DOI: 10.1016/j.cct.2015.09.017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
12 St-Jules DE, Watters CA, Nagamori K, King J. The effect of weight loss on pediatric nonalcoholic Fatty liver disease. ISRN Gastroenterol. 2013;2013:398297. [PMID: 23781345 DOI: 10.1155/2013/398297] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Xiang X, Guo Y, Yang L, Ge Q, Mijit S, Xu F. Association of human leukocyte antigen DP/DQ gene polymorphisms with chronic hepatitis B in Chinese Han and Uygur populations. Infect Genet Evol 2016;43:407-11. [PMID: 27291710 DOI: 10.1016/j.meegid.2016.06.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
14 Geurtsen ML, Wahab RJ, Felix JF, Gaillard R, Jaddoe VWV. Maternal Early-Pregnancy Glucose Concentrations and Liver Fat Among School-Age Children. Hepatology 2021. [PMID: 34008183 DOI: 10.1002/hep.31910] [Reference Citation Analysis]
15 Saab S, Manne V, Nieto J, Schwimmer JB, Chalasani NP. Nonalcoholic Fatty Liver Disease in Latinos. Clinical Gastroenterology and Hepatology 2016;14:5-12. [DOI: 10.1016/j.cgh.2015.05.001] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 8.7] [Reference Citation Analysis]
16 Barshop NJ, Sirlin CB, Schwimmer JB, Lavine JE. Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease: REVIEW: PAEDIATRIC NON-ALCOHOLIC FATTY LIVER DISEASE. Alimentary Pharmacology & Therapeutics 2008;28:13-24. [DOI: 10.1111/j.1365-2036.2008.03703.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 94] [Article Influence: 6.4] [Reference Citation Analysis]
17 Choi YS, Klaric JS, Beltran TH. Prediction of Insulin Resistance with Anthropometric and Clinical Laboratory Measures in Nondiabetic Teenagers. Metabolic Syndrome and Related Disorders 2019;17:37-45. [DOI: 10.1089/met.2018.0072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
18 Kim JS, Lê KA, Mahurkar S, Davis JN, Goran MI. Influence of elevated liver fat on circulating adipocytokines and insulin resistance in obese Hispanic adolescents. Pediatr Obes 2012;7:158-64. [PMID: 22434756 DOI: 10.1111/j.2047-6310.2011.00014.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
19 Santiprabhob J, Leewanun C, Limprayoon K, Kiattisakthavee P, Wongarn R, Aanpreung P, Likitmaskul S. Outcomes of group-based treatment program with parental involvement for the management of childhood and adolescent obesity. Patient Educ Couns 2014;97:67-74. [PMID: 25053472 DOI: 10.1016/j.pec.2014.07.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
20 Yu EL, Schwimmer JB, Lavine JE. Non-alcoholic fatty liver disease: epidemiology, pathophysiology, diagnosis and treatment. Paediatrics and Child Health 2010;20:26-9. [DOI: 10.1016/j.paed.2009.09.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
21 Maahs DM, Daniels SR, de Ferranti SD, Dichek HL, Flynn J, Goldstein BI, Kelly AS, Nadeau KJ, Martyn-Nemeth P, Osganian SK, Quinn L, Shah AS, Urbina E; American Heart Association Atherosclerosis; Hypertension and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council for High Blood Pressure Research; and Council on Lifestyle and Cardiometabolic Health. Cardiovascular disease risk factors in youth with diabetes mellitus: a scientific statement from the American Heart Association. Circulation. 2014;130:1532-1558. [PMID: 25170098 DOI: 10.1161/cir.0000000000000094] [Cited by in Crossref: 107] [Cited by in F6Publishing: 59] [Article Influence: 13.4] [Reference Citation Analysis]
22 Tokuhara D. Role of the Gut Microbiota in Regulating Non-alcoholic Fatty Liver Disease in Children and Adolescents. Front Nutr 2021;8:700058. [PMID: 34250000 DOI: 10.3389/fnut.2021.700058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Harmon RC, Caldwell SH. Propensity for non-alcoholic fatty liver disease: more evidence for ethnic susceptibility. Liver International 2009;29:4-5. [DOI: 10.1111/j.1478-3231.2008.01959.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
24 Sharp DB, Santos LA, Cruz ML. Fatty liver in adolescents on the U.S.-Mexico border. Journal of the American Academy of Nurse Practitioners 2009;21:225-30. [DOI: 10.1111/j.1745-7599.2009.00397.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
25 Nobili V, Alisi A, Newton KP, Schwimmer JB. Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2016;150:1798-1810. [PMID: 27003600 DOI: 10.1053/j.gastro.2016.03.009] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 11.5] [Reference Citation Analysis]
26 Burgert TS, Taksali SE, Dziura J, Goodman TR, Yeckel CW, Papademetris X, Constable RT, Weiss R, Tamborlane WV, Savoye M. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab. 2006;91:4287-4294. [PMID: 16912127 DOI: 10.1210/jc.2006-1010] [Cited by in Crossref: 252] [Cited by in F6Publishing: 233] [Article Influence: 15.8] [Reference Citation Analysis]
27 Smith RW, Korenblum C, Thacker K, Bonifacio HJ, Gonska T, Katzman DK. Severely elevated transaminases in an adolescent male with anorexia nervosa: Severely Elevated Transaminases in Male With AN. Int J Eat Disord 2013;46:751-4. [DOI: 10.1002/eat.22162] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
28 Bambha K, Belt P, Abraham M, Wilson LA, Pabst M, Ferrell L, Unalp-Arida A, Bass N;  Nonalcoholic Steatohepatitis Clinical Research Network Research Group. Ethnicity and nonalcoholic fatty liver disease. Hepatology. 2012;55:769-780. [PMID: 21987488 DOI: 10.1002/hep.24726] [Cited by in Crossref: 130] [Cited by in F6Publishing: 125] [Article Influence: 13.0] [Reference Citation Analysis]
29 Fernandes M, Ferraro A, De Azevedo R, Fagundes Neto U. Metabolic differences between male and female adolescents with non-alcoholic fatty liver disease, as detected by ultrasound: Metabolic differences between male and female adolescents. Acta Paediatrica 2010;99:1218-23. [DOI: 10.1111/j.1651-2227.2010.01774.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
30 Dunn W, Schwimmer JB. The obesity epidemic and nonalcoholic fatty liver disease in children. Curr Gastroenterol Rep 2008;10:67-72. [DOI: 10.1007/s11894-008-0011-1] [Cited by in Crossref: 71] [Cited by in F6Publishing: 70] [Article Influence: 5.1] [Reference Citation Analysis]
31 Mencin AA, Loomba R, Lavine JE. Caring for children with NAFLD and navigating their care into adulthood. Nat Rev Gastroenterol Hepatol 2015;12:617-28. [PMID: 26323878 DOI: 10.1038/nrgastro.2015.146] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
32 Koebnick C, Getahun D, Reynolds K, Coleman KJ, Porter AH, Lawrence JM, Punyanitya M, Quinn VP, Jacobsen SJ. Trends in Nonalcoholic Fatty Liver Disease–related Hospitalizations in US Children, Adolescents, and Young Adults. Journal of Pediatric Gastroenterology & Nutrition 2009;48:597-603. [DOI: 10.1097/mpg.0b013e318192d224] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
33 Shapiro WL, Noon SL, Schwimmer JB. Recent advances in the epidemiology of nonalcoholic fatty liver disease in children. Pediatr Obes 2021;16:e12849. [PMID: 34498413 DOI: 10.1111/ijpo.12849] [Reference Citation Analysis]
34 Alavian SM, Mohammad-Alizadeh AH, Esna-Ashari F, Ardalan G, Hajarizadeh B. Non-alcoholic fatty liver disease prevalence among school-aged children and adolescents in Iran and its association with biochemical and anthropometric measures. Liver Int 2009;29:159-63. [PMID: 18492015 DOI: 10.1111/j.1478-3231.2008.01790.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
35 Lückhoff HK, Kruger FC, Kotze MJ. Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries. World J Hepatol 2015; 7(9): 1192-1208 [PMID: 26019735 DOI: 10.4254/wjh.v7.i9.1192] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
36 Fraser A, Longnecker MP, Lawlor DA. Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. Gastroenterology. 2007;133:1814-1820. [PMID: 18054554 DOI: 10.1053/j.gastro.207.08.077] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Baskar S, Jhaveri S, Alkhouri N. Cardiovascular risk in pediatric nonalcoholic fatty liver disease: recent advances. Clinical Lipidology 2015;10:351-62. [DOI: 10.2217/clp.15.26] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
38 Achmad E, Yokoo T, Hamilton G, Heba ER, Hooker JC, Changchien C, Schroeder M, Wolfson T, Gamst A, Schwimmer JB, Lavine JE, Sirlin CB, Middleton MS. Feasibility of and agreement between MR imaging and spectroscopic estimation of hepatic proton density fat fraction in children with known or suspected nonalcoholic fatty liver disease. Abdom Imaging 2015;40:3084-90. [PMID: 26205992 DOI: 10.1007/s00261-015-0506-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
39 De Bruyne RM, Fitzpatrick E, Dhawan A. Fatty liver disease in children: eat now pay later. Hepatol Int. 2010;4:375-385. [PMID: 20305757 DOI: 10.1007/s12072-009-9160-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
40 Kallwitz ER, Kumar M, Aggarwal R, Berger R, Layden-Almer J, Gupta N, Cotler SJ. Ethnicity and nonalcoholic fatty liver disease in an obesity clinic: the impact of triglycerides. Dig Dis Sci. 2008;53:1358-1363. [PMID: 18347982 DOI: 10.1007/s10620-008-0234-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
41 Mannery YO, McClain CJ, Vos MB. Keratin 18, Apoptosis, and Liver Disease in Children. Curr Pediatr Rev 2011;7:310-5. [PMID: 25346653 DOI: 10.2174/157339611796892364] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
42 Moriyama K, Urata N, Masuda Y, Oda K, Okuno C, Yamada C, Takashimizu S, Kubo A, Kishimoto N, Nishizaki Y. Usefulness of Triglyceride to High-Density Lipoprotein Ratio and Alanine Aminotransferase for Predicting Insulin Resistance and Metabolic Syndrome in the Japanese Population. Metab Syndr Relat Disord 2021;19:225-32. [PMID: 33577395 DOI: 10.1089/met.2020.0121] [Reference Citation Analysis]
43 Balagopal PB, de Ferranti SD, Cook S, Daniels SR, Gidding SS, Hayman LL, McCrindle BW, Mietus-Snyder ML, Steinberger J. Nontraditional risk factors and biomarkers for cardiovascular disease: mechanistic, research, and clinical considerations for youth: a scientific statement from the American Heart Association. Circulation. 2011;123:2749-2769. [PMID: 21555711 DOI: 10.1161/cir.0b013e31821c7c64] [Cited by in Crossref: 208] [Cited by in F6Publishing: 90] [Article Influence: 18.9] [Reference Citation Analysis]
44 Alisi A, Manco M, Panera N, Nobili V. Association between type two diabetes and non-alcoholic fatty liver disease in youth. Annals of Hepatology 2009;8:S44-50. [DOI: 10.1016/s1665-2681(19)31826-5] [Cited by in Crossref: 23] [Article Influence: 1.8] [Reference Citation Analysis]
45 Cantoral A, Montoya A, Luna-Villa L, Roldán-Valadez EA, Hernández-Ávila M, Kershenobich D, Perng W, Peterson KE, Hu H, Rivera JA, Téllez-Rojo MM. Overweight and obesity status from the prenatal period to adolescence and its association with non-alcoholic fatty liver disease in young adults: cohort study. BJOG 2020;127:1200-9. [PMID: 32145139 DOI: 10.1111/1471-0528.16199] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
46 Loomba R, Sirlin CB, Schwimmer JB, Lavine JE. Advances in pediatric nonalcoholic fatty liver disease. Hepatology. 2009;50:1282-1293. [PMID: 19637286 DOI: 10.1002/hep.23119] [Cited by in Crossref: 181] [Cited by in F6Publishing: 159] [Article Influence: 13.9] [Reference Citation Analysis]
47 Wadsworth T, Pendergast PM. Obesity (Sometimes) Matters: The Importance of Context in the Relationship between Obesity and Life Satisfaction. J Health Soc Behav 2014;55:196-214. [PMID: 24872467 DOI: 10.1177/0022146514533347] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
48 Lindbäck SM, Gabbert C, Johnson BL, Smorodinsky E, Sirlin CB, Garcia N, Pardee PE, Kistler KD, Schwimmer JB. Pediatric Nonalcoholic Fatty Liver Disease: A Comprehensive Review. Advances in Pediatrics 2010;57:85-140. [DOI: 10.1016/j.yapd.2010.08.006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
49 Newton KP, Hou J, Crimmins NA, Lavine JE, Barlow SE, Xanthakos SA, Africa J, Behling C, Donithan M, Clark JM, Schwimmer JB; Nonalcoholic Steatohepatitis Clinical Research Network. Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease. JAMA Pediatr 2016;170:e161971. [PMID: 27478956 DOI: 10.1001/jamapediatrics.2016.1971] [Cited by in Crossref: 103] [Cited by in F6Publishing: 90] [Article Influence: 17.2] [Reference Citation Analysis]
50 Mohammadi F, Qorbani M, Kelishadi R, Baygi F, Ardalan G, Taslimi M, Mahmoudarabi M, Motlagh M, Asayesh H, Larijani B, Heshmat R. Association of Cardiometabolic Risk Factors and Hepatic Enzymes in a National Sample of Iranian Children and Adolescents: The CASPIAN-III Study. Journal of Pediatric Gastroenterology & Nutrition 2014;58:463-8. [DOI: 10.1097/mpg.0000000000000246] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
51 Welsh JA, Karpen S, Vos MB. Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010. J Pediatr 2013;162:496-500.e1. [PMID: 23084707 DOI: 10.1016/j.jpeds.2012.08.043] [Cited by in Crossref: 279] [Cited by in F6Publishing: 250] [Article Influence: 27.9] [Reference Citation Analysis]
52 Milroy CM. Fatty Liver and the Forensic Pathologist. Acad Forensic Pathol 2018;8:296-310. [PMID: 31240043 DOI: 10.1177/1925362118782061] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
53 Andrade GCD, Fujise LH, Santana Filho JED, Oliveira F, Silva RDCMAD. Non-alcoholic fatty liver disease (NAFLD) in different populations: A clinical and epidemiological study – sample of São José do Rio Preto. Rev Assoc Med Bras 2016;62:218-26. [DOI: 10.1590/1806-9282.62.03.218] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
54 Khatatbeh M, Momani W, Altaani Z, Al Saad R, Al Bourah AR. Fast Food Consumption, Liver Functions, and Change in Body Weight Among University Students: A Cross-Sectional Study. Int J Prev Med 2021;12:109. [PMID: 34760120 DOI: 10.4103/ijpvm.IJPVM_194_19] [Reference Citation Analysis]
55 Okuda M, Kunitsugu I, Yoshitake N, Hinoda Y, Suehiro Y, Okuda Y, Hobara T. Variance in the transaminase levels over the body mass index spectrum in 10- and 13-year-olds. Pediatr Int 2010;52:813-9. [PMID: 20487366 DOI: 10.1111/j.1442-200X.2010.03167.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
56 Choi MH, Choi J, Park MY, Rha SE, Oh SN, Jung SE, Byun JY, Kannengiesser S, Son Y. Validation of intimate correlation between visceral fat and hepatic steatosis: Quantitative measurement techniques using CT for area of fat and MR for hepatic steatosis. Clinical Nutrition 2018;37:214-22. [DOI: 10.1016/j.clnu.2016.12.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
57 Grotti Clemente AP, Molin Netto BD, Ganen Ad, Tock L, Arisa Caranti D, de Mello MT, Tufik S, Dâmaso AR. Cut-Off Values of Visceral Adiposity to Predict NAFLD in Brazilian Obese Adolescents. J Nutr Metab 2013;2013:724781. [PMID: 24381750 DOI: 10.1155/2013/724781] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
58 Bussler S, Vogel M, Pietzner D, Harms K, Buzek T, Penke M, Händel N, Körner A, Baumann U, Kiess W, Flemming G. New pediatric percentiles of liver enzyme serum levels (alanine aminotransferase, aspartate aminotransferase, γ‐glutamyltransferase): Effects of age, sex, body mass index, and pubertal stage. Hepatology 2018;68:1319-30. [DOI: 10.1002/hep.29542] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 12.0] [Reference Citation Analysis]
59 Kim G, Giannini C, Pierpont B, Feldstein AE, Santoro N, Kursawe R, Shaw M, Duran E, Goldberg R, Dziura J. Longitudinal effects of MRI-measured hepatic steatosis on biomarkers of glucose homeostasis and hepatic apoptosis in obese youth. Diabetes Care. 2013;36:130-136. [PMID: 22933439 DOI: 10.2337/dc12-0277] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
60 Barshop NJ, Francis CS, Schwimmer JB, Lavine JE. Nonalcoholic fatty liver disease as a comorbidity of childhood obesity. Ped Health. 2009;3:271-281. [PMID: 20556232 DOI: 10.2217/phe.09.21] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
61 Alkassabany YM, Farghaly AG, El-Ghitany EM. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt. Arab J Gastroenterol 2014;15:76-81. [PMID: 25097051 DOI: 10.1016/j.ajg.2014.05.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
62 Schwimmer JB, Ugalde-Nicalo P, Welsh JA, Angeles JE, Cordero M, Harlow KE, Alazraki A, Durelle J, Knight-Scott J, Newton KP, Cleeton R, Knott C, Konomi J, Middleton MS, Travers C, Sirlin CB, Hernandez A, Sekkarie A, McCracken C, Vos MB. Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys: A Randomized Clinical Trial. JAMA 2019;321:256-65. [PMID: 30667502 DOI: 10.1001/jama.2018.20579] [Cited by in Crossref: 73] [Cited by in F6Publishing: 62] [Article Influence: 24.3] [Reference Citation Analysis]
63 Gracious BL, Bhatt R, Potter C. Nonalcoholic Fatty Liver Disease and Fibrosis in Youth Taking Psychotropic Medications: Literature Review, Case Reports, and Management. Journal of Child and Adolescent Psychopharmacology 2015;25:602-10. [DOI: 10.1089/cap.2015.0007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
64 Hudson OD, Nunez M, Shaibi GQ. Ethnicity and elevated liver transaminases among newly diagnosed children with type 2 diabetes. BMC Pediatr 2012;12:174. [PMID: 23134937 DOI: 10.1186/1471-2431-12-174] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
65 Ko JS. Nonalcoholic Fatty Liver Disease. Korean J Gastroenterol 2010;56:6. [DOI: 10.4166/kjg.2010.56.1.6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
66 Zhao Y, Yu Y, Li H, Li M, Zhang D, Guo D, Yu X, Lu C, Wang H. The Association between Metabolic Syndrome and Biochemical Markers in Beijing Adolescents. Int J Environ Res Public Health 2019;16:E4557. [PMID: 31752150 DOI: 10.3390/ijerph16224557] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
67 Devadason CA, Scheimann AO. Overview of screening methods for fatty liver disease in children. World J Hepatol 2012; 4(1): 1-4 [PMID: 22312449 DOI: 10.4254/wjh.v4.i1.1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
68 Quirós-Tejeira RE, Rivera CA, Ziba TT, Mehta N, Smith CW, Butte NF. Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI & gt; or =95th percentile. J Pediatr Gastroenterol Nutr. 2007;44:228-236. [PMID: 17255837 DOI: 10.1097/mpg.0b013e31802d4acc] [Cited by in Crossref: 79] [Cited by in F6Publishing: 38] [Article Influence: 5.3] [Reference Citation Analysis]
69 Fermin CR, Lee AM, Filipp SL, Gurka MJ, DeBoer MD. Serum Alanine Aminotransferase Trends and Their Relationship with Obesity and Metabolic Syndrome in United States Adolescents, 1999-2014. Metab Syndr Relat Disord 2017;15:276-82. [PMID: 28520503 DOI: 10.1089/met.2017.0023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
70 Barr MM, Aslibekyan S, Ashraf AP. Glycemic control and lipid outcomes in children and adolescents with type 2 diabetes. PLoS One 2019;14:e0219144. [PMID: 31260475 DOI: 10.1371/journal.pone.0219144] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
71 Nadeau KJ, Ehlers LB, Zeitler PS, Love-Osborne K. Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents. Pediatr Diabetes. 2009;10:5-13. [PMID: 18721166 DOI: 10.1111/j.1399-5448.2008.00450.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 4.4] [Reference Citation Analysis]
72 Song P, Yu J, Wang M, Chang X, Wang J, An L. Prevalence and Correlates of Suspected Nonalcoholic Fatty Liver Disease in Chinese Children. Int J Environ Res Public Health 2017;14:E465. [PMID: 28448433 DOI: 10.3390/ijerph14050465] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
73 Kallwitz ER, Guzman G, TenCate V, Vitello J, Layden-Almer J, Berkes J, Patel R, Layden TJ, Cotler SJ. The histologic spectrum of liver disease in African-American, non-Hispanic white, and Hispanic obesity surgery patients. Am J Gastroenterol. 2009;104:64-69. [PMID: 19098851 DOI: 10.1038/ajg.2008.12] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
74 Ozkol M, Ersoy B, Kasirga E, Taneli F, Bostanci IE, Ozhan B. Metabolic predictors for early identification of fatty liver using doppler and B-mode ultrasonography in overweight and obese adolescents. Eur J Pediatr 2010;169:1345-52. [DOI: 10.1007/s00431-010-1227-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
75 Papandreou D, Rousso I, Mavromichalis I. Update on non-alcoholic fatty liver disease in children. Clinical Nutrition 2007;26:409-15. [DOI: 10.1016/j.clnu.2007.02.002] [Cited by in Crossref: 77] [Cited by in F6Publishing: 82] [Article Influence: 5.1] [Reference Citation Analysis]
76 Nobili V, Manco M. Therapeutic strategies for pediatric non-alcoholic fatty liver disease: A challenge for health care providers. World J Gastroenterol 2007; 13(18): 2639-2641 [PMID: 17552019 DOI: 10.3748/wjg.v13.i18.2639] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
77 Labayen I, Ruiz JR, Ortega FB, Davis CL, Rodríguez G, González-Gross M, Breidenassel C, Dallongeville J, Marcos A, Widhalm K, Kafatos A, Molnar D, DeHenauw S, Gottrand F, Moreno LA. Liver enzymes and clustering cardiometabolic risk factors in European adolescents: the HELENA study. Pediatr Obes 2015;10:361-70. [PMID: 25515703 DOI: 10.1111/ijpo.273] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
78 Lawlor DA, Callaway M, Macdonald-Wallis C, Anderson E, Fraser A, Howe LD, Day C, Sattar N. Nonalcoholic fatty liver disease, liver fibrosis, and cardiometabolic risk factors in adolescence: a cross-sectional study of 1874 general population adolescents. J Clin Endocrinol Metab. 2014;99:E410-E417. [PMID: 24471572 DOI: 10.1210/jc.2013-3612] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 5.4] [Reference Citation Analysis]
79 Padilha PDC, Rocha HFD, Alves N, Peres WAF. Prevalência de doença hepática não-alcoólica em crianças e adolescentes obesos: uma revisão sistemática. Rev paul pediatr 2010;28:387-93. [DOI: 10.1590/s0103-05822010000400016] [Cited by in Crossref: 6] [Article Influence: 0.5] [Reference Citation Analysis]
80 Isasi CR, Rastogi D, Molina K. Health Issues in Hispanic/Latino Youth. J Lat Psychol 2016;4:67-82. [PMID: 27347457 DOI: 10.1037/lat0000054] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
81 Koutny F, Weghuber D, Bollow E, Greber-Platzer S, Hartmann K, Körner A, Reinehr T, Roebl M, Simic-Schleicher G, Wabitsch M, Widhalm K, Wiegand S, Holl RW. Prevalence of prediabetes and type 2 diabetes in children with obesity and increased transaminases in European German-speaking countries. Analysis of the APV initiative. Pediatr Obes 2020;15:e12601. [PMID: 31810110 DOI: 10.1111/ijpo.12601] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
82 Arshad T, Paik JM, Biswas R, Alqahtani SA, Henry L, Younossi ZM. Nonalcoholic Fatty Liver Disease Prevalence Trends Among Adolescents and Young Adults in the United States, 2007-2016. Hepatol Commun 2021;5:1676-88. [PMID: 34558817 DOI: 10.1002/hep4.1760] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Kabir A, Pourshams A, Khoshnia M, Malekzadeh F. Normal limit for serum alanine aminotransferase level and distribution of metabolic factors in old population of kalaleh, iran. Hepat Mon 2013;13:e10640. [PMID: 24348633 DOI: 10.5812/hepatmon.10640] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
84 Lin YC, Chang PF, Hu FC, Yang WS, Chang MH, Ni YH. A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children. J Pediatr. 2011;158:740-744. [PMID: 21168155 DOI: 10.1016/j.jpeds.2010.11.016] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 5.0] [Reference Citation Analysis]
85 Imhof A, Kratzer W, Boehm B, Meitinger K, Trischler G, Steinbach G, Piechotowski I, Koenig W. Prevalence of non-alcoholic fatty liver and characteristics in overweight adolescents in the general population. Eur J Epidemiol 2007;22:889-97. [DOI: 10.1007/s10654-007-9181-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
86 Bozic MA, Subbarao G, Molleston JP. Pediatric Nonalcoholic Fatty Liver Disease. Nutr Clin Pract 2013;28:448-58. [DOI: 10.1177/0884533613489153] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
87 Vidmar AP, Jones RB, Wee CP, Berger PK, Plows JF, Claudia Rios RD, Raymond JK, Goran MI. Timing of food consumption in Hispanic adolescents with obesity. Pediatr Obes 2021;16:e12764. [PMID: 33370849 DOI: 10.1111/ijpo.12764] [Reference Citation Analysis]
88 Nunes MMDA, Medeiros CC, Silva LR. Cholelithiasis in obese adolescents treated at an outpatient clinic. Jornal de Pediatria 2014;90:203-8. [DOI: 10.1016/j.jped.2013.08.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
89 Middleton JP, Wiener RC, Barnes BH, Gurka MJ, DeBoer MD. Clinical features of pediatric nonalcoholic fatty liver disease: a need for increased awareness and a consensus for screening. Clin Pediatr (Phila) 2014;53:1318-25. [PMID: 24477713 DOI: 10.1177/0009922813520072] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
90 do Nascimento JH, Epifanio M, Soder RB, Baldisserotto M. MRI-diagnosed nonalcoholic fatty liver disease is correlated to insulin resistance in adolescents. Acad Radiol 2013;20:1436-42. [PMID: 24119357 DOI: 10.1016/j.acra.2013.08.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
91 Patel DA, Srinivasan SR, Chen W, Berenson GS. Serum alanine aminotransferase and its association with metabolic syndrome in children: the bogalusa heart study. Metab Syndr Relat Disord 2011;9:211-6. [PMID: 21476865 DOI: 10.1089/met.2010.0086] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
92 Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, Benson JT, Enders FB, Angulo P. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut 2009;58:1538-44. [PMID: 19625277 DOI: 10.1136/gut.2008.171280] [Cited by in Crossref: 414] [Cited by in F6Publishing: 389] [Article Influence: 31.8] [Reference Citation Analysis]
93 Mencin AA, Lavine JE. Advances in pediatric nonalcoholic fatty liver disease. Pediatr Clin North Am. 2011;58:1375-1392, x. [PMID: 22093857 DOI: 10.1016/j.pcl.2011.09.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
94 Faienza MF, Chiarito M, Molina-Molina E, Shanmugam H, Lammert F, Krawczyk M, D'Amato G, Portincasa P. Childhood obesity, cardiovascular and liver health: a growing epidemic with age. World J Pediatr 2020;16:438-45. [PMID: 32020441 DOI: 10.1007/s12519-020-00341-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
95 Labayen I, Ruiz JR, Huybrechts I, Ortega FB, Castillo M, Sjöstrom M, González-Gross M, Manios Y, Widhalm K, Kafatos A, Breidenassel C, Rodríguez G, Dallongeville J, Gottrand F, Moreno LA. Ideal cardiovascular health and liver enzyme levels in European adolescents; the HELENA study. J Physiol Biochem 2017;73:225-34. [PMID: 28063097 DOI: 10.1007/s13105-016-0546-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
96 Takahashi Y, Fukusato T. Pediatric nonalcoholic fatty liver disease: Overview with emphasis on histology. World J Gastroenterol 2010; 16(42): 5280-5285 [PMID: 21072890 DOI: 10.3748/wjg.v16.i42.5280] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
97 Jin R, Le NA, Cleeton R, Sun X, Cruz Muños J, Otvos J, Vos MB. Amount of hepatic fat predicts cardiovascular risk independent of insulin resistance among Hispanic-American adolescents. Lipids Health Dis 2015;14:39. [PMID: 25925168 DOI: 10.1186/s12944-015-0038-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
98 Malik JA, Coto J, Pulgaron ER, Daigre A, Sanchez JE, Goldberg RB, Wilson DK, Delamater AM. Sedentary behavior moderates the relationship between physical activity and cardiometabolic risk in young Latino children. Transl Behav Med 2021:ibab046. [PMID: 33999199 DOI: 10.1093/tbm/ibab046] [Reference Citation Analysis]
99 Chen SC, Huang YF, Wang JD. Hyperferritinemia and hyperuricemia may be associated with liver function abnormality in obese adolescents. PLoS One 2012;7:e48645. [PMID: 23119080 DOI: 10.1371/journal.pone.0048645] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
100 Teran-Garcia M, Rankinen T, Bouchard C. Genes, exercise, growth, and the sedentary, obese child. J Appl Physiol (1985) 2008;105:988-1001. [PMID: 18535128 DOI: 10.1152/japplphysiol.00070.2008] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
101 Wattacheril J, Lavine JE, Chalasani NP, Guo X, Kwon S, Schwimmer J, Molleston JP, Loomba R, Brunt EM, Chen YI, Goodarzi MO, Taylor KD, Yates KP, Tonascia J, Rotter JI. Genome-Wide Associations Related to Hepatic Histology in Nonalcoholic Fatty Liver Disease in Hispanic Boys. J Pediatr 2017;190:100-107.e2. [PMID: 28918882 DOI: 10.1016/j.jpeds.2017.08.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
102 Uppal V, Mansoor S, Furuya KN. Pediatric Non-alcoholic Fatty Liver Disease. Curr Gastroenterol Rep 2016;18:24. [PMID: 27086005 DOI: 10.1007/s11894-016-0498-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
103 Manco M, Bottazzo G, Devito R, Marcellini M, Mingrone G, Nobili V. Nonalcoholic Fatty Liver Disease in Children. Journal of the American College of Nutrition 2008;27:667-76. [DOI: 10.1080/07315724.2008.10719744] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
104 Carrion AF, Ghanta R, Carrasquillo O, Martin P. Chronic liver disease in the Hispanic population of the United States. Clin Gastroenterol Hepatol 2011;9:834-41; quiz e109-10. [PMID: 21628000 DOI: 10.1016/j.cgh.2011.04.027] [Cited by in Crossref: 63] [Cited by in F6Publishing: 54] [Article Influence: 5.7] [Reference Citation Analysis]
105 Purcell M, Flores YN, Zhang Z, Denova-gutiérrez E, Salmeron J. Prevalence and predictors of alanine aminotransferase elevation among normal weight, overweight and obese youth in Mexico: Elevated ALT risk among youth in Mexico. Journal of Digestive Diseases 2013;14:491-9. [DOI: 10.1111/1751-2980.12072] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
106 Pacifico L, Poggiogalle E, Cantisani V, Menichini G, Ricci P, Ferraro F, Chiesa C. Pediatric nonalcoholic fatty liver disease: A clinical and laboratory challenge. World J Hepatol 2010; 2(7): 275-288 [PMID: 21161009 DOI: 10.4254/wjh.v2.i7.275] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
107 Fu JF, Shi HB, Liu LR, Jiang P, Liang L, Wang CL, Liu XY. Non-alcoholic fatty liver disease: An early mediator predicting metabolic syndrome in obese children? World J Gastroenterol 2011; 17(6): 735-742 [PMID: 21390143 DOI: 10.3748/wjg.v17.i6.735] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 48] [Article Influence: 4.5] [Reference Citation Analysis]
108 Marzuillo P, Miraglia del Giudice E, Santoro N. Pediatric fatty liver disease: Role of ethnicity and genetics. World J Gastroenterol 2014; 20(23): 7347-7355 [PMID: 24966605 DOI: 10.3748/wjg.v20.i23.7347] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 35] [Article Influence: 5.5] [Reference Citation Analysis]
109 Huang JS, Barlow SE, Quiros-Tejeira RE, Scheimann A, Skelton J, Suskind D, Tsai P, Uko V, Warolin JP, Xanthakos SA. Childhood obesity for pediatric gastroenterologists. J Pediatr Gastroenterol Nutr. 2013;56:99-109. [PMID: 23282941 DOI: 10.1097/mpg.0b013e31826d3c62] [Cited by in Crossref: 38] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
110 Denzer C, Thiere D, Muche R, Koenig W, Mayer H, Kratzer W, Wabitsch M. Gender-specific prevalences of fatty liver in obese children and adolescents: roles of body fat distribution, sex steroids, and insulin resistance. J Clin Endocrinol Metab. 2009;94:3872-3881. [PMID: 19773396 DOI: 10.1210/jc.2009-1125] [Cited by in Crossref: 80] [Cited by in F6Publishing: 74] [Article Influence: 6.2] [Reference Citation Analysis]
111 Clemente AP, Netto BD, de Carvalho-Ferreira JP, da Silveira Campos RM, de Piano Ganen A, Tock L, de Mello MT, Dâmaso AR. [Waist circumference as a marker for screening nonalcoholic fatty liver disease in obese adolescents]. Rev Paul Pediatr 2016;34:47-55. [PMID: 26830602 DOI: 10.1016/j.rpped.2015.05.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
112 Leite N, Tadiotto MC, Corazza PRP, de Menezes Junior FJ, Carli MEC, Milano-Gai GE, Lopes WA, Gaya AR, Brand C, Mota J, Radominski RB. Responsiveness on metabolic syndrome criteria and hepatic parameters after 12 weeks and 24 weeks of multidisciplinary intervention in overweight adolescents. J Endocrinol Invest 2021. [PMID: 34780051 DOI: 10.1007/s40618-021-01699-x] [Reference Citation Analysis]
113 Akın L, Kurtoglu S, Yikilmaz A, Kendirci M, Elmalı F, Mazicioglu M. Fatty liver is a good indicator of subclinical atherosclerosis risk in obese children and adolescents regardless of liver enzyme elevation. Acta Paediatr 2013;102:e107-13. [DOI: 10.1111/apa.12099] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
114 Blomme B, Fitzpatrick E, Quaglia A, De Bruyne R, Dhawan A, Van Vlierberghe H. Serum protein N-glycosylation in paediatric non-alcoholic fatty liver disease. Pediatr Obes 2012;7:165-73. [PMID: 22434757 DOI: 10.1111/j.2047-6310.2011.00024.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
115 Wong CA, Araneta MR, Barrett-Connor E, Alcaraz J, Castañeda D, Macera C. Probable NAFLD, by ALT levels, and diabetes among Filipino-American women. Diabetes Res Clin Pract 2008;79:133-40. [PMID: 17764776 DOI: 10.1016/j.diabres.2007.07.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
116 Larrieta-carrasco E, León-mimila P, Villarreal-molina T, Villamil-ramírez H, Romero-hidalgo S, Jacobo-albavera L, Gutiérrez-vidal R, López-contreras BE, Guillén-pineda LE, Sánchez-muñoz F, Bojalil R, Mejía-domínguez AM, Méndez-sánchez N, Domínguez-lópez A, Aguilar-salinas CA, Canizales-quinteros S. Association of the I148M/PNPLA3 variant with elevated alanine transaminase levels in normal-weight and overweight/obese Mexican children. Gene 2013;520:185-8. [DOI: 10.1016/j.gene.2013.03.038] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
117 Kwon KA, Chun P, Park JH. Clinical significance of serum alanine aminotransferase and lifestyle intervention in children with nonalcoholic fatty liver disease. Korean J Pediatr 2016;59:362-7. [PMID: 27721840 DOI: 10.3345/kjp.2016.59.9.362] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
118 Huang SC, Yang YJ. Serum retinol-binding protein 4 is independently associated with pediatric NAFLD and fasting triglyceride level. J Pediatr Gastroenterol Nutr 2013;56:145-50. [PMID: 22983378 DOI: 10.1097/MPG.0b013e3182722aee] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
119 Alisi A, Manco M, Vania A, Nobili V. Pediatric Nonalcoholic Fatty Liver Disease in 2009. The Journal of Pediatrics 2009;155:469-74. [DOI: 10.1016/j.jpeds.2009.06.014] [Cited by in Crossref: 86] [Cited by in F6Publishing: 80] [Article Influence: 6.6] [Reference Citation Analysis]
120 Dalla Valle M, Laatikainen T, Kalliokoski T, Nykänen P, Jääskeläinen J. Childhood obesity in specialist care – searching for a healthy obese child. Annals of Medicine 2015;47:639-54. [DOI: 10.3109/07853890.2015.1083118] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
121 Lonardo A, Caldwell SH, Loria P. Clinical physiology of NAFLD: a critical overview of pathogenesis and treatment. Expert Review of Endocrinology & Metabolism 2014;5:403-23. [DOI: 10.1586/eem.10.5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
122 Elizondo-Montemayor L, Ugalde-Casas PA, Lam-Franco L, Bustamante-Careaga H, Serrano-González M, Gutiérrez NG, Martínez U. Association of ALT and the metabolic syndrome among Mexican children. Obes Res Clin Pract 2014;8:e79-87. [PMID: 24548580 DOI: 10.1016/j.orcp.2012.08.191] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
123 Carrillo-Iregui A, Lopez-Mitnik G, Cossio S, Garibay-Nieto N, Arheart KL, Messiah SE. Relationship between aminotransferases levels and components of the metabolic syndrome among multiethnic adolescents. J Pediatr Endocrinol Metab 2010;23:1253-61. [PMID: 21714459 DOI: 10.1515/jpem.2010.199] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
124 Litwin T, Gromadzka G, Członkowska A. Gender differences in Wilson's disease. Journal of the Neurological Sciences 2012;312:31-5. [DOI: 10.1016/j.jns.2011.08.028] [Cited by in Crossref: 81] [Cited by in F6Publishing: 69] [Article Influence: 8.1] [Reference Citation Analysis]
125 Chen S, Guo X, Yu S, Zhou Y, Li Z, Sun Y. Anthropometric Indices in Adults: Which Is the Best Indicator to Identify Alanine Aminotransferase Levels? Int J Environ Res Public Health 2016;13:226. [PMID: 26901214 DOI: 10.3390/ijerph13020226] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
126 Radwan MM, Radwan BM, Nandipati KC, Hunter WJ, Agrawal DK. Immunological and molecular basis of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease. Expert Rev Clin Immunol. 2013;9:727-738. [PMID: 23971751 DOI: 10.1586/1744666x.2013.816484] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
127 Deboer MD, Wiener RC, Barnes BH, Gurka MJ. Ethnic differences in the link between insulin resistance and elevated ALT. Pediatrics. 2013;132:e718-726. [PMID: 23940240 DOI: 10.1542/peds.2012-3584] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
128 Goffredo M, Santoro N, Tricò D, Giannini C, D'Adamo E, Zhao H, Peng G, Yu X, Lam TT, Pierpont B, Caprio S, Herzog RI. A Branched-Chain Amino Acid-Related Metabolic Signature Characterizes Obese Adolescents with Non-Alcoholic Fatty Liver Disease. Nutrients 2017;9:E642. [PMID: 28640216 DOI: 10.3390/nu9070642] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 11.4] [Reference Citation Analysis]
129 Zaman A, Arif Z, Moinuddin, Akhtar K, Ali WM, Alam K. A study on hepatopathic, dyslipidemic and immunogenic properties of fructosylated-HSA-AGE and binding of autoantibodies in sera of obese and overweight patients with fructosylated-HSA-AGE. PLoS One 2019;14:e0216736. [PMID: 31116779 DOI: 10.1371/journal.pone.0216736] [Reference Citation Analysis]
130 Walker RW, Sinatra F, Hartiala J, Weigensberg M, Spruijt-Metz D, Alderete TL, Goran MI, Allayee H. Genetic and clinical markers of elevated liver fat content in overweight and obese Hispanic children. Obesity (Silver Spring) 2013;21:E790-7. [PMID: 23804528 DOI: 10.1002/oby.20523] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
131 Kistler KD, Molleston J, Unalp A, Abrams SH, Behling C, Schwimmer JB; Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN). Symptoms and quality of life in obese children and adolescents with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2010;31:396-406. [PMID: 19863497 DOI: 10.1111/j.1365-2036.2009.04181.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 4.0] [Reference Citation Analysis]
132 Roberts EA. Non-alcoholic steatohepatitis in children. Clin Liver Dis. 2007;11:155-172, x. [PMID: 17544977 DOI: 10.1016/j.cld.2007.02.008] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.6] [Reference Citation Analysis]
133 Alisi A, Feldstein AE, Villani A, Raponi M, Nobili V. Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach. Nat Rev Gastroenterol Hepatol 2012;9:152-61. [DOI: 10.1038/nrgastro.2011.273] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 7.1] [Reference Citation Analysis]
134 Alfire ME, Treem WR. Nonalcoholic fatty liver disease. Pediatr Ann 2006;35:290-4, 297-9. [PMID: 16637558 DOI: 10.3928/0090-4481-20060401-14] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
135 Bayat M, Erdem E, Barik O, Başer M, Taşci S. Blood pressure, height, weight and body mass index of primary school students in a low socio-economic district in Turkey. Int Nurs Rev 2009;56:375-80. [PMID: 19702813 DOI: 10.1111/j.1466-7657.2009.00722.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
136 Bettermann K, Hohensee T, Haybaeck J. Steatosis and steatohepatitis: complex disorders. Int J Mol Sci. 2014;15:9924-9944. [PMID: 24897026 DOI: 10.3390/ijms15069924] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
137 Patel KR, White FV, Deutsch GH. Hepatic steatosis is prevalent in stillborns delivered to women with diabetes mellitus. J Pediatr Gastroenterol Nutr. 2015;60:152-158. [PMID: 25079479 DOI: 10.1097/mpg.0000000000000520] [Cited by in Crossref: 36] [Cited by in F6Publishing: 17] [Article Influence: 5.1] [Reference Citation Analysis]
138 Wong WW, Mikhail C, Ortiz CL, Lathan D, Moore LA, Konzelmann KL, Smith EO. Body weight has no impact on self-esteem of minority children living in inner city, low-income neighborhoods: a cross-sectional study. BMC Pediatr 2014;14:19. [PMID: 24456638 DOI: 10.1186/1471-2431-14-19] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
139 Marin V, Rosso N, Dal Ben M, Raseni A, Boschelle M, Degrassi C, Nemeckova I, Nachtigal P, Avellini C, Tiribelli C, Gazzin S. An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. PLoS One 2016;11:e0158817. [PMID: 27391242 DOI: 10.1371/journal.pone.0158817] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
140 Hsu E, Murray K. Is nonalcoholic fatty liver disease in children the same disease as in adults? Clin Liver Dis 2012;16:587-98. [PMID: 22824482 DOI: 10.1016/j.cld.2012.05.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
141 Greenfield V, Cheung O, Sanyal AJ. Recent advances in nonalcholic fatty liver disease. Curr Opin Gastroenterol. 2008;24:320-327. [PMID: 18408460 DOI: 10.1097/mog.0b013e3282fbccf2] [Cited by in Crossref: 74] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
142 Gupta R, Bhangoo A, Matthews NA, Anhalt H, Matta Y, Lamichhane B, Malik S, Narwal S, Wetzler G, Ten S. The prevalence of non-alcoholic fatty liver disease and metabolic syndrome in obese children. J Pediatr Endocrinol Metab. 2011;24:907-911. [PMID: 22308841 DOI: 10.1515/jpem.2011.282] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
143 Mann JP, De Vito R, Mosca A, Alisi A, Armstrong MJ, Raponi M, Baumann U, Nobili V. Portal inflammation is independently associated with fibrosis and metabolic syndrome in pediatric nonalcoholic fatty liver disease. Hepatology. 2016;63:745-753. [PMID: 26638195 DOI: 10.1002/hep.28374] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 7.3] [Reference Citation Analysis]
144 Lee S, Kuk JL, Boesch C, Arslanian S. Waist circumference is associated with liver fat in black and white adolescents. Appl Physiol Nutr Metab. 2017;42:829-833. [PMID: 28334548 DOI: 10.1139/apnm-2016-0410] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
145 González Jiménez E, Schmidt Río-Valle J, Álvarez Ferre J. [Fatty liver and its clinical management in obese adolescents]. Endocrinol Nutr 2011;58:32-7. [PMID: 21216209 DOI: 10.1016/j.endonu.2010.10.005] [Reference Citation Analysis]
146 Boodai SA, Cherry LM, Sattar NA, Reilly JJ. Prevalence of cardiometabolic risk factors and metabolic syndrome in obese Kuwaiti adolescents. Diabetes Metab Syndr Obes 2014;7:505-11. [PMID: 25368527 DOI: 10.2147/DMSO.S66156] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
147 Cusi K. The Epidemic of Type 2 Diabetes Mellitus: Its Links to Obesity, Insulin Resistance, and Lipotoxicity. In: Regensteiner JG, Reusch JE, Stewart KJ, Veves A, editors. Diabetes and Exercise. Totowa: Humana Press; 2009. pp. 3-54. [DOI: 10.1007/978-1-59745-260-1_1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
148 Peng L, Wu S, Zhou N, Zhu S, Liu Q, Li X. Clinical characteristics and risk factors of nonalcoholic fatty liver disease in children with obesity.BMC Pediatr. 2021;21:122. [PMID: 33711964 DOI: 10.1186/s12887-021-02595-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
149 Mohanty SR, Troy TN, Huo D, O'Brien BL, Jensen DM, Hart J. Influence of ethnicity on histological differences in non-alcoholic fatty liver disease. J Hepatol 2009;50:797-804. [PMID: 19231016 DOI: 10.1016/j.jhep.2008.11.017] [Cited by in Crossref: 85] [Cited by in F6Publishing: 87] [Article Influence: 6.5] [Reference Citation Analysis]
150 Hesham A-Kader H. Nonalcoholic fatty liver disease in children living in the obeseogenic society. World J Pediatr. 2009;5:245-254. [PMID: 19911138 DOI: 10.1007/s12519-009-0048-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
151 Bayol SA, Simbi BH, Fowkes RC, Stickland NC. A maternal "junk food" diet in pregnancy and lactation promotes nonalcoholic Fatty liver disease in rat offspring. Endocrinology 2010;151:1451-61. [PMID: 20207831 DOI: 10.1210/en.2009-1192] [Cited by in Crossref: 96] [Cited by in F6Publishing: 84] [Article Influence: 8.0] [Reference Citation Analysis]
152 Conjeevaram Selvakumar PK, Kabbany MN, Alkhouri N. Nonalcoholic Fatty Liver Disease in Children: Not a Small Matter. Paediatr Drugs. 2018;20:315-329. [PMID: 29740791 DOI: 10.1007/s40272-018-0292-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
153 Perito ER, Rodriguez LA, Lustig RH. Dietary treatment of nonalcoholic steatohepatitis. Curr Opin Gastroenterol 2013;29:170-6. [PMID: 23283181 DOI: 10.1097/MOG.0b013e32835ca11d] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
154 Ibele AR, Mattar SG. Adolescent Bariatric Surgery. Surgical Clinics of North America 2011;91:1339-51. [DOI: 10.1016/j.suc.2011.08.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
155 Widhalm K, Ghods E. Nonalcoholic fatty liver disease: a challenge for pediatricians. Int J Obes 2010;34:1451-67. [DOI: 10.1038/ijo.2010.185] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 3.7] [Reference Citation Analysis]
156 Vos MB, Lavine JE. Dietary fructose in nonalcoholic fatty liver disease. Hepatology 2013;57:2525-31. [DOI: 10.1002/hep.26299] [Cited by in Crossref: 180] [Cited by in F6Publishing: 170] [Article Influence: 20.0] [Reference Citation Analysis]
157 Schwimmer JB, Pardee PE, Lavine JE, Blumkin AK, Cook S. Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation. 2008;118:277-283. [PMID: 18591439 DOI: 10.1161/circulationaha.107.739920] [Cited by in Crossref: 246] [Cited by in F6Publishing: 133] [Article Influence: 17.6] [Reference Citation Analysis]
158 Mărginean CO, Meliț LE, Săsăran MO. Metabolic Associated Fatty Liver Disease in Children-From Atomistic to Holistic. Biomedicines 2021;9:1866. [PMID: 34944682 DOI: 10.3390/biomedicines9121866] [Reference Citation Analysis]
159 Messiah SE, Vidot DC, Baeker Bispo J, Arheart KL, Khorgami Z, De La Cruz-muñoz N. Ethnic and Gender Differences in the Prevalence of Nonalcoholic Steatohepatitis Among Bariatric Surgery Patients. Bariatric Surgical Practice and Patient Care 2016;11:153-7. [DOI: 10.1089/bari.2016.0018] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
160 Nobili V, Reale A, Alisi A, Morino G, Trenta I, Pisani M, Marcellini M, Raucci U. Elevated serum ALT in children presenting to the emergency unit: Relationship with NAFLD. Digestive and Liver Disease 2009;41:749-52. [DOI: 10.1016/j.dld.2009.02.048] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
161 Corte CD, Ferrari F, Villani A, Nobili V. Epidemiology and Natural History of NAFLD. J Med Biochem 2015;34:13-7. [PMID: 28356818 DOI: 10.2478/jomb-2014-0049] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
162 Chashmniam S, Ghafourpour M, Rezaei Farimani A, Gholami A, Nobakht Motlagh Ghoochani BF. Metabolomic Biomarkers in the Diagnosis of Non-Alcoholic Fatty Liver Disease. Hepat Mon 2019;19. [DOI: 10.5812/hepatmon.92244] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
163 Benetolo PO, Fernandes MIM, Ciampo IRLD, Elias-Junior J, Sawamura R. Evaluation of nonalcoholic fatty liver disease using magnetic resonance in obese children and adolescents. J Pediatr (Rio J). 2019;95:34-40. [PMID: 29438686 DOI: 10.1016/j.jped.2017.12.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
164 Kosters A, Sun D, Wu H, Tian F, Felix JC, Li W, Karpen SJ. Sexually dimorphic genome-wide binding of retinoid X receptor alpha (RXRα) determines male-female differences in the expression of hepatic lipid processing genes in mice. PLoS One 2013;8:e71538. [PMID: 23977068 DOI: 10.1371/journal.pone.0071538] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
165 Schwimmer JB, Celedon MA, Lavine JE, Salem R, Campbell N, Schork NJ, Shiehmorteza M, Yokoo T, Chavez A, Middleton MS, Sirlin CB. Heritability of nonalcoholic fatty liver disease. Gastroenterology 2009;136:1585-92. [PMID: 19208353 DOI: 10.1053/j.gastro.2009.01.050] [Cited by in Crossref: 292] [Cited by in F6Publishing: 266] [Article Influence: 22.5] [Reference Citation Analysis]
166 Dowla S, Aslibekyan S, Goss A, Fontaine K, Ashraf AP. Dyslipidemia is associated with pediatric nonalcoholic fatty liver disease. J Clin Lipidol 2018;12:981-7. [PMID: 29699915 DOI: 10.1016/j.jacl.2018.03.089] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
167 Denzer C. [Non-alcoholic fatty liver disease in obese children and adolescents]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013;56:517-27. [PMID: 23529597 DOI: 10.1007/s00103-012-1639-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
168 Robinson A, Tavakoli H, Liu B, Bhuket T, Cheung R, Wong RJ. African-Americans with Cirrhosis Are Less Likely to Receive Endoscopic Variceal Screening Within One Year of Cirrhosis Diagnosis. J Racial Ethn Health Disparities 2018;5:860-6. [PMID: 29052175 DOI: 10.1007/s40615-017-0432-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
169 Perseghin G, Bonfanti R, Magni S, Lattuada G, De Cobelli F, Canu T, Esposito A, Scifo P, Ntali G, Costantino F, Bosio L, Ragogna F, Del Maschio A, Chiumello G, Luzi L. Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease. Am J Physiol Endocrinol Metab 2006;291:E697-703. [PMID: 16684857 DOI: 10.1152/ajpendo.00017.2006] [Cited by in Crossref: 75] [Cited by in F6Publishing: 71] [Article Influence: 4.7] [Reference Citation Analysis]
170 Shneider BL, González-peralta R, Roberts EA. Controversies in the management of pediatric liver disease: Hepatitis B, C and NAFLD: Summary of a single topic conference. Hepatology 2006;44:1344-54. [DOI: 10.1002/hep.21373] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.0] [Reference Citation Analysis]
171 Bahreynian M, Qorbani M, Motlagh ME, Heshmat R, Khademian M, Kelishadi R. Association of Serum 25-hydroxyvitamin D Levels and Liver Enzymes in a Nationally Representative Sample of Iranian Adolescents: The Childhood and Adolescence Surveillance and Prevention of Adult Noncommunicable Disease Study. Int J Prev Med 2018;9:24. [PMID: 29619148 DOI: 10.4103/ijpvm.IJPVM_37_18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
172 Antunes Bde M, Monteiro PA, Silveira LS, Cayres SU, Silva CB, F IF Jr. Effect of concurrent training on risk factors and hepatic steatosis in obese adolescents. Rev Paul Pediatr 2013;31:371-6. [PMID: 24142321 DOI: 10.1590/S0103-05822013000300015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
173 Kolahdoozan S, Mirminachi B, Sepanlou SG, Malekzadeh R, Merat S, Poustchi H. Upper Normal Limits of Serum Alanine Aminotransferase in Healthy Population: A Systematic Review. Middle East J Dig Dis 2020;12:194-205. [PMID: 33062225 DOI: 10.34172/mejdd.2020.182] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
174 Bussler S, Penke M, Flemming G, Elhassan YS, Kratzsch J, Sergeyev E, Lipek T, Vogel M, Spielau U, Körner A, de Giorgis T, Kiess W. Novel Insights in the Metabolic Syndrome in Childhood and Adolescence. Horm Res Paediatr 2017;88:181-93. [PMID: 28848168 DOI: 10.1159/000479510] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 9.0] [Reference Citation Analysis]
175 Verhulst SL, Jacobs S, Aerts L, Schrauwen N, Haentjens D, Rooman RP, Gaal LV, De Backer WA, Desager KN. Sleep-disordered breathing: a new risk factor of suspected fatty liver disease in overweight children and adolescents? Sleep Breath 2009;13:207-10. [DOI: 10.1007/s11325-008-0231-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
176 Chen ZW, Chen LY, Dai HL, Chen JH, Fang LZ. Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease. J Zhejiang Univ Sci B. 2008;9:616-622. [PMID: 18763311 DOI: 10.1631/jzus.b0720016] [Cited by in Crossref: 53] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
177 Adams LA, White SW, Marsh JA, Lye SJ, Connor KL, Maganga R, Ayonrinde OT, Olynyk JK, Mori TA, Beilin LJ. Association between liver-specific gene polymorphisms and their expression levels with nonalcoholic fatty liver disease. Hepatology. 2013;57:590-600. [PMID: 23213074 DOI: 10.1002/hep.26184] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 6.0] [Reference Citation Analysis]
178 Brown RE, Kuk JL. Consequences of obesity and weight loss: a devil's advocate position. Obes Rev 2015;16:77-87. [PMID: 25410935 DOI: 10.1111/obr.12232] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
179 van Vliet M, von Rosenstiel IA, Schindhelm RK, Brandjes DPM, Beijnen JH, Diamant M. The association of elevated alanine aminotransferase and the metabolic syndrome in an overweight and obese pediatric population of multi-ethnic origin. Eur J Pediatr 2009;168:585-91. [DOI: 10.1007/s00431-008-0802-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
180 Fraser A, Longnecker MP, Lawlor DA. Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. Gastroenterology. 2007;133:1814-1820. [PMID: 18054554 DOI: 10.1053/j.gastro.2007.08.077] [Cited by in Crossref: 222] [Cited by in F6Publishing: 219] [Article Influence: 14.8] [Reference Citation Analysis]
181 Chen SC, Yeh JJ, Chang MH, Liao YK, Hsiao LC, Neoh CA, Tok TS, Wang JD. Gender difference of alanine aminotransferase elevation may be associated with higher hemoglobin levels among male adolescents. PLoS One 2010;5:e13269. [PMID: 20967274 DOI: 10.1371/journal.pone.0013269] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
182 Gökçe S, Atbinici Z, Aycan Z, Çınar HG, Zorlu P. The Relationship Between Pediatric Nonalcoholic Fatty Liver Disease and Cardiovascular Risk Factors and Increased Risk of Atherosclerosis in Obese Children. Pediatr Cardiol 2013;34:308-15. [DOI: 10.1007/s00246-012-0447-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
183 Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The epidemiology of obesity. Gastroenterology. 2007;132:2087-2102. [PMID: 17498505 DOI: 10.1053/j.gastro.2007.03.052] [Cited by in Crossref: 952] [Cited by in F6Publishing: 844] [Article Influence: 63.5] [Reference Citation Analysis]
184 Lin YC, Wu CC, Ni YH. New Perspectives on Genetic Prediction for Pediatric Metabolic Associated Fatty Liver Disease. Front Pediatr 2020;8:603654. [PMID: 33363067 DOI: 10.3389/fped.2020.603654] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
185 Liccardo D, Alisi A, Porta G, Nobili V. Is there any link between dietary pattern and development of nonalcoholic fatty liver disease in adolescence? An expert review. Expert Rev Gastroenterol Hepatol 2013;7:601-4. [PMID: 24070151 DOI: 10.1586/17474124.2013.827483] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
186 Lonardo A, Carani C, Carulli N, Loria P. ‘Endocrine NAFLD’ a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis. J Hepatol. 2006;44:1196-1207. [PMID: 16618516 DOI: 10.1016/j.jhep.2006.03.005] [Cited by in Crossref: 83] [Cited by in F6Publishing: 84] [Article Influence: 5.2] [Reference Citation Analysis]
187 Kheirandish-gozal L, Sans Capdevila O, Kheirandish E, Gozal D. Elevated Serum Aminotransferase Levels in Children at Risk for Obstructive Sleep Apnea. Chest 2008;133:92-9. [DOI: 10.1378/chest.07-0773] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 4.9] [Reference Citation Analysis]
188 Gilsanz V, Chung SA, Kaplowitz N. Differential effect of gender on hepatic fat. Pediatr Radiol 2011;41:1146-53. [PMID: 21404026 DOI: 10.1007/s00247-011-2021-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
189 Christian Flemming GM, Bussler S, Körner A, Kiess W. Definition and early diagnosis of metabolic syndrome in children. J Pediatr Endocrinol Metab 2020;33:821-33. [PMID: 32568734 DOI: 10.1515/jpem-2019-0552] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
190 Yarrington CD, Cantonwine DE, Seely EW, Mcelrath TF, Zera CA. The Association of Alanine Aminotransferase in Early Pregnancy with Gestational Diabetes. Metabolic Syndrome and Related Disorders 2016;14:254-8. [DOI: 10.1089/met.2015.0106] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
191 Roberts EA. Pediatric nonalcoholic fatty liver disease (NAFLD): A “growing” problem? Journal of Hepatology 2007;46:1133-42. [DOI: 10.1016/j.jhep.2007.03.003] [Cited by in Crossref: 123] [Cited by in F6Publishing: 102] [Article Influence: 8.2] [Reference Citation Analysis]
192 Liska D, Dufour S, Zern TL, Taksali S, Calí AM, Dziura J, Shulman GI, Pierpont BM, Caprio S. Interethnic differences in muscle, liver and abdominal fat partitioning in obese adolescents. PLoS ONE. 2007;2:e569. [PMID: 17593968 DOI: 10.1371/journal.pone.0000569] [Cited by in Crossref: 98] [Cited by in F6Publishing: 90] [Article Influence: 6.5] [Reference Citation Analysis]
193 Bernal C, Martín-pozuelo G, Lozano AB, Sevilla Á, García-alonso J, Canovas M, Periago MJ. Lipid biomarkers and metabolic effects of lycopene from tomato juice on liver of rats with induced hepatic steatosis. The Journal of Nutritional Biochemistry 2013;24:1870-81. [DOI: 10.1016/j.jnutbio.2013.05.003] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
194 Jimenez-Rivera C, Hadjiyannakis S, Davila J, Hurteau J, Aglipay M, Barrowman N, Adamo KB. Prevalence and risk factors for non-alcoholic fatty liver in children and youth with obesity. BMC Pediatr 2017;17:113. [PMID: 28446162 DOI: 10.1186/s12887-017-0867-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
195 Reichman TW, Therapondos G, Serrano MS, Seal J, Evers-Meltzer R, Bohorquez H, Cohen A, Carmody I, Ahmed E, Bruce D, Loss GE. “Weighing the risk”: Obesity and outcomes following liver transplantation. World J Hepatol 2015; 7(11): 1484-1493 [PMID: 26085908 DOI: 10.4254/wjh.v7.i11.1484] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
196 Eklioğlu BS, Atabek ME, Akyürek N, Alp H. Assessment of Cardiovascular Parameters in Obese Children and Adolescents with Non-Alcoholic Fatty Liver Disease. J Clin Res Pediatr Endocrinol 2015;7:222-7. [PMID: 26831557 DOI: 10.4274/jcrpe.1949] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
197 Merrell MD, Cherrington NJ. Drug metabolism alterations in nonalcoholic fatty liver disease.Drug Metab Rev. 2011;43:317-334. [PMID: 21612324 DOI: 10.3109/03602532.2011.577781] [Cited by in Crossref: 103] [Cited by in F6Publishing: 87] [Article Influence: 9.4] [Reference Citation Analysis]
198 Schwimmer JB, Newton KP, Awai HI, Choi LJ, Garcia MA, Ellis LL, Vanderwall K, Fontanesi J. Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2013;38:1267-77. [PMID: 24117728 DOI: 10.1111/apt.12518] [Cited by in Crossref: 96] [Cited by in F6Publishing: 88] [Article Influence: 10.7] [Reference Citation Analysis]
199 Hakim O, Bello O, Ladwa M, Christodoulou D, Bulut E, Shuaib H, Peacock JL, Umpleby AM, Charles-Edwards G, Amiel SA, Goff LM. Ethnic differences in hepatic, pancreatic, muscular and visceral fat deposition in healthy men of white European and black west African ethnicity. Diabetes Res Clin Pract 2019;156:107866. [PMID: 31542318 DOI: 10.1016/j.diabres.2019.107866] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
200 Bass R, Eneli I. Severe childhood obesity: an under-recognised and growing health problem. Postgrad Med J 2015;91:639-45. [PMID: 26338983 DOI: 10.1136/postgradmedj-2014-133033] [Cited by in Crossref: 65] [Cited by in F6Publishing: 54] [Article Influence: 9.3] [Reference Citation Analysis]
201 Harrison-Findik DD. Gender-related variations in iron metabolism and liver diseases. World J Hepatol 2010; 2(8): 302-310 [PMID: 21161013 DOI: 10.4254/wjh.v2.i8.302] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
202 Graham RC, Burke A, Stettler N. Ethnic and sex differences in the association between metabolic syndrome and suspected nonalcoholic fatty liver disease in a nationally representative sample of US adolescents. J Pediatr Gastroenterol Nutr. 2009;49:442-449. [PMID: 19644391 DOI: 10.1097/mpg.0b013e31819f73b4] [Cited by in Crossref: 40] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
203 Patton HM, Sirlin C, Behling C, Middleton M, Schwimmer JB, Lavine JE. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research. J Pediatr Gastroenterol Nutr. 2006;43:413-427. [PMID: 17033514 DOI: 10.1097/01.mpg.0000239995.58388.56] [Cited by in Crossref: 164] [Cited by in F6Publishing: 150] [Article Influence: 10.3] [Reference Citation Analysis]
204 Nobili V, Svegliati-baroni G, Alisi A, Miele L, Valenti L, Vajro P. A 360-degree overview of paediatric NAFLD: Recent insights. Journal of Hepatology 2013;58:1218-29. [DOI: 10.1016/j.jhep.2012.12.003] [Cited by in Crossref: 106] [Cited by in F6Publishing: 99] [Article Influence: 11.8] [Reference Citation Analysis]
205 do Nascimento JH, Soder RB, Epifanio M, Baldisserotto M. Accuracy of computer-aided ultrasound as compared with magnetic resonance imaging in the evaluation of nonalcoholic fatty liver disease in obese and eutrophic adolescents. Radiol Bras 2015;48:225-32. [PMID: 26379321 DOI: 10.1590/0100-3984.2014.0074] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
206 Chavez-Tapia NC, Sanchez-Avila F, Vasquez-Fernandez F, Torres-Machorro A, Tellez-Avila FI, Uribe M. Non-alcoholic fatty-liver disease in pediatric populations. J Pediatr Endocrinol Metab 2007;20:1059-73. [PMID: 18051925 DOI: 10.1515/jpem.2007.20.10.1059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
207 Schwimmer JB, Behling C, Newbury R, Deutsch R, Nievergelt C, Schork NJ, Lavine JE. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology. 2005;42:641-649. [PMID: 16116629 DOI: 10.1002/hep.20842] [Cited by in Crossref: 488] [Cited by in F6Publishing: 435] [Article Influence: 28.7] [Reference Citation Analysis]
208 Mager DR, Yap J, Rodriguez-Dimitrescu C, Mazurak V, Ball G, Gilmour S. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease. Nutr Clin Pract 2013;28:101-11. [PMID: 23042833 DOI: 10.1177/0884533612454884] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
209 Della Corte C, Alisi A, Saccari A, De Vito R, Vania A, Nobili V. Nonalcoholic fatty liver in children and adolescents: an overview. J Adolesc Health. 2012;51:305-312. [PMID: 22999829 DOI: 10.1016/j.jadohealth.2012.01.010] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
210 Leung DH, Williams K, Fraley JK, Klish WJ. Age- and ethnic-specific elevation of ALT among obese children at risk for nonalcoholic steatohepatitis (NASH): implications for screening. Clin Pediatr (Phila) 2009;48:50-7. [PMID: 18832535 DOI: 10.1177/0009922808321678] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
211 Li W, Homer K, Hull S, Boomla K, Robson J, Alazawi W. Obesity Predicts Liver Function Testing and Abnormal Liver Results. Obesity (Silver Spring) 2020;28:132-8. [PMID: 31804018 DOI: 10.1002/oby.22669] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
212 Karnes JH, Arora A, Feng J, Steiner HE, Sulieman L, Boerwinkle E, Clark C, Cicek M, Cohn E, Gebo K, Loperena-Cortes R, Ohno-Machado L, Mayo K, Mockrin S, Ramirez A, Schully S, Klimentidis YC. Racial, ethnic, and gender differences in obesity and body fat distribution: An All of Us Research Program demonstration project. PLoS One 2021;16:e0255583. [PMID: 34358277 DOI: 10.1371/journal.pone.0255583] [Reference Citation Analysis]
213 Yoo J, Lee S, Kim K, Yoo S, Sung E, Yim J. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children. Diabetes Res Clin Pract 2008;81:321-6. [PMID: 18571268 DOI: 10.1016/j.diabres.2008.05.006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
214 Ochiai H, Shirasawa T, Nishimura R, Nanri H, Ohtsu T, Hoshino H, Tajima N, Kokaze A. Waist-to-height ratio is more closely associated with alanine aminotransferase levels than body mass index and waist circumference among population-based children: a cross-sectional study in Japan. BMC Pediatr 2015;15:59. [PMID: 25980380 DOI: 10.1186/s12887-015-0378-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
215 Verrotti A, Agostinelli S, Parisi P, Chiarelli F, Coppola G. Nonalcoholic fatty liver disease in adolescents receiving valproic acid. Epilepsy Behav. 2011;20:382-385. [PMID: 21256090 DOI: 10.1016/j.yebeh.2010.12.012] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
216 Ghergherehchi R, Hazhir N, Mostafa Gharehbaghi M. Lifestyle Intervention and Vitamin E Therapy in Obese Children with Nonalcoholic Fatty Liver Disease. J Compr Ped 2012;4:62-5. [DOI: 10.17795/compreped-6249] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
217 Radulescu A, Dugan AJ, Killian M, Attia SL, Mouzaki M, Fuchs GJ, Kohli R, Bada H, Kern PA, Softic S. Stratification by obesity class, rather than age, can identify a higher percent of children at risk for non-alcoholic fatty liver disease and metabolic dysfunction. Pediatr Obes 2021;:e12862. [PMID: 34662928 DOI: 10.1111/ijpo.12862] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
218 Souza MRDA, Diniz MDFFDM, Medeiros-filho JEMD, Araújo MSTD. Metabolic syndrome and risk factors for non-alcoholic fatty liver disease. Arq Gastroenterol 2012;49:89-96. [DOI: 10.1590/s0004-28032012000100015] [Cited by in Crossref: 102] [Cited by in F6Publishing: 72] [Article Influence: 10.2] [Reference Citation Analysis]
219 Fang YL, Chen H, Wang CL, Liang L. Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From “two hit theory” to “multiple hit model”. World J Gastroenterol 2018; 24(27): 2974-2983 [PMID: 30038464 DOI: 10.3748/wjg.v24.i27.2974] [Cited by in CrossRef: 89] [Cited by in F6Publishing: 73] [Article Influence: 22.3] [Reference Citation Analysis]
220 Love-Osborne KA, Nadeau KJ, Sheeder J, Fenton LZ, Zeitler P. Presence of the metabolic syndrome in obese adolescents predicts impaired glucose tolerance and nonalcoholic fatty liver disease. J Adolesc Health 2008;42:543-8. [PMID: 18486862 DOI: 10.1016/j.jadohealth.2007.11.136] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
221 Oh JE, Jung J, Kim HS, Hong YM, Yoo JH, Song YW, Jung JW, Kim NS, Noh CI. Clinical characteristics of obese boys and girls in a high school: focused on abdominal fat indices, fatty liver and carotid intima-media thickness. Korean J Pediatr 2011;54:292-7. [PMID: 22025922 DOI: 10.3345/kjp.2011.54.7.292] [Reference Citation Analysis]
222 Wieckowska A, Feldstein AE. Nonalcoholic fatty liver disease in the pediatric population: a review. Curr Opin Pediatr. 2005;17:636-641. [PMID: 16160540 DOI: 10.1097/01.mop.0000172816.79637.c5] [Cited by in Crossref: 85] [Cited by in F6Publishing: 79] [Article Influence: 5.3] [Reference Citation Analysis]
223 Giorgio V, Prono F, Graziano F, Nobili V. Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets. BMC Pediatr. 2013;13:40. [PMID: 23530957 DOI: 10.1186/1471-2431-13-40] [Cited by in Crossref: 95] [Cited by in F6Publishing: 89] [Article Influence: 10.6] [Reference Citation Analysis]
224 Verma S, Jensen D, Hart J, Mohanty SR. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD). Liver Int. 2013;33:1398-1405. [PMID: 23763360 DOI: 10.1111/liv.12226] [Cited by in Crossref: 143] [Cited by in F6Publishing: 132] [Article Influence: 15.9] [Reference Citation Analysis]
225 Vos MB, Barve S, Joshi-Barve S, Carew JD, Whitington PF, McClain CJ. Cytokeratin 18, a marker of cell death, is increased in children with suspected nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr. 2008;47:481-485. [PMID: 18852641 DOI: 10.1097/mpg.0b013e31817e2bfb] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
226 Katz K, Brar PC, Parekh N, Liu YH, Weitzman M. Suspected nonalcoholic Fatty liver disease is not associated with vitamin d status in adolescents after adjustment for obesity. J Obes 2010;2010:496829. [PMID: 21331294 DOI: 10.1155/2010/496829] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
227 Ayonrinde OT, Olynyk JK, Beilin LJ, Mori TA, Pennell CE, de Klerk N, Oddy WH, Shipman P, Adams LA. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease. Hepatology 2011;53:800-9. [PMID: 21374659 DOI: 10.1002/hep.24097] [Cited by in Crossref: 137] [Cited by in F6Publishing: 126] [Article Influence: 12.5] [Reference Citation Analysis]
228 Rocha R, Cotrim HP, Bitencourt AGV, Barbosa DBV, Santos AS, Almeida AM, Cunha B, Guimarães I. Nonalcoholic fatty liver disease in asymptomatic Brazilian adolescents. World J Gastroenterol 2009; 15(4): 473-477 [PMID: 19152453 DOI: 10.3748/wjg.15.473] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
229 Malpique R, Bassols J, López-bermejo A, Diaz M, Villarroya F, Pavia J, Congo A, de Zegher F, Ibáñez L. Liver volume and hepatic adiposity in childhood: relations to body growth and visceral fat. Int J Obes 2018;42:65-71. [DOI: 10.1038/ijo.2017.198] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
230 Hattar LN, Wilson TA, Tabotabo LA, Smith EO, Abrams SH. Physical activity and nutrition attitudes in obese Hispanic children with non-alcoholic steatohepatitis. World J Gastroenterol 2011; 17(39): 4396-4403 [PMID: 22110265 DOI: 10.3748/wjg.v17.i39.4396] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
231 Daniels SR. Complications of obesity in children and adolescents. Int J Obes (Lond) 2009;33 Suppl 1:S60-5. [PMID: 19363511 DOI: 10.1038/ijo.2009.20] [Cited by in Crossref: 309] [Cited by in F6Publishing: 283] [Article Influence: 25.8] [Reference Citation Analysis]
232 Stovitz SD, Schwimmer JB, Martinez H, Story MT. Pediatric obesity: the unique issues in Latino-American male youth. Am J Prev Med 2008;34:153-60. [PMID: 18201646 DOI: 10.1016/j.amepre.2007.09.034] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
233 Delvin E, Patey N, Dubois J, Henderson M, Lévy É. Pediatric Non-Alcoholic Fatty Liver Disease. J Med Biochem 2015;34:3-12. [PMID: 28356817 DOI: 10.2478/jomb-2014-0059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
234 Brumbaugh DE, Friedman JE. Developmental origins of nonalcoholic fatty liver disease. Pediatr Res 2014;75:140-7. [PMID: 24192698 DOI: 10.1038/pr.2013.193] [Cited by in Crossref: 86] [Cited by in F6Publishing: 80] [Article Influence: 9.6] [Reference Citation Analysis]
235 Lu Y, Wang Q, Yu L, Yin X, Yang H, Xu X, Xia Y, Luo Y, Peng Y, Yu Q, Chen Z, Yu J, Lai M, Wu N, Pan XB, Zheng X. Revision of serum ALT upper limits of normal facilitates assessment of mild liver injury in obese children with non-alcoholic fatty liver disease. J Clin Lab Anal 2020;34:e23285. [PMID: 32267017 DOI: 10.1002/jcla.23285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
236 Holterman AX, Guzman G, Fantuzzi G, Wang H, Aigner K, Browne A, Holterman M. Nonalcoholic fatty liver disease in severely obese adolescent and adult patients. Obesity (Silver Spring). 2013;21:591-597. [PMID: 23592668 DOI: 10.1002/oby.20174] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
237 Engelmann G, Hoffmann GF, Grulich-Henn J, Teufel U. Alanine aminotransferase elevation in obese infants and children: a marker of early onset non alcoholic Fatty liver disease. Hepat Mon 2014;14:e14112. [PMID: 24748893 DOI: 10.5812/hepatmon.14112] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]